Novel TWISTARE MRI technique shows potential for faster quantitative T2 brain mapping in preclinical validation
This preclinical validation study assessed TWISTARE (TWo Interleaved Steady-states for T2 and RF Estimation), a novel dual steady-state 3D-GRE MRI technique using interleaved flip angles and small RF phase increments for quantitative T2 and B1 mapping at 7T. The study, conducted in a laboratory/imaging research setting, compared the technique to an unspecified gold-standard method. The population and sample size were not reported.
In phantom experiments, the technique achieved high precision, though specific effect sizes and absolute numbers were not provided. The method demonstrated up to a two-fold reduction in acquisition time. In-vivo results showed comparable precision and similar scan duration to the gold-standard method. No p-values or confidence intervals were reported for these comparisons.
Safety, tolerability, and adverse events were not reported. Key limitations were not explicitly listed in the provided data, and funding or conflicts of interest were not reported. The study's certainty is limited as it is a preclinical validation study involving Bloch simulations, phantom studies, and in-vivo imaging, with no human clinical trial data.
For practice, this technical development offers potential benefits for clinical and research applications, particularly in longitudinal and dynamic studies of brain tissue in conditions like neurodegenerative diseases. However, clinicians should interpret these findings cautiously, as the evidence does not support statements about clinical efficacy, diagnostic accuracy in patients, safety profile, or comparative effectiveness beyond the stated technical metrics. The technique requires validation in clinical trials.